ECM
AERI

ExodusPoint Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

ExodusPoint Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-47,605
Closed -$720K – 2312
2022
Q3 		$720K Buy
+47,605
New +$553K 0.01% 1239
2022
Q2 		– Sell
-75,097
Closed -$683K – 2717
2022
Q1 		$683K Sell
75,097
-12,958
-15% -$99.9K 0.01% 1359
2021
Q4 		$618K Buy
88,055
+68,388
+348% +$716K 0.01% 1287
2021
Q3 		$224K Sell
19,667
-19,419
-50% -$284K ﹤0.01% 1743
2021
Q2 		$626K Buy
39,086
+7,527
+24% +$129K 0.01% 1242
2021
Q1 		$564K Buy
+31,559
New +$545K 0.01% 1259
2020
Q3 		– Sell
-27,013
Closed -$399K – 2373
2020
Q2 		$399K Buy
+27,013
New +$400K 0.01% 1185
2019
Q4 		– Sell
-19,642
Closed -$378K – 1996
2019
Q3 		$378K Buy
19,642
+2,221
+13% +$50.9K 0.01% 784
2019
Q2 		$515K Buy
+17,421
New +$671K 0.02% 459

ExodusPoint Capital Management's AERI Position: Q4 2022 in Review

ExodusPoint Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 47,605 shares — an estimated $720K sold.

ExodusPoint Capital Management first reported a position in AERI in Q2 2019 and held it in 9 quarters. The position peaked at $720K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • ExodusPoint Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • ExodusPoint Capital Management sold 47,605 Aerie Pharmaceuticals shares in Q4 2022, an estimated $720K.
  • ExodusPoint Capital Management first reported a position in Aerie Pharmaceuticals in Q2 2019 and held it in 9 quarters.
  • ExodusPoint Capital Management's Aerie Pharmaceuticals position peaked at $720K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.